Diabexa

A division of Positive Medicare

Diabexa, a division of Positive Medicare, is dedicated to providing high-quality diabetic medicines and fostering strong partnerships within the healthcare community. Our WHO GMP (World Health Organization Good Manufacturing Practices) certification is a testament to our unwavering commitment to the highest international standards in pharmaceutical manufacturing. This rigorous certification process ensures that all our 100+ brands of diabetic medicines are produced under strict quality control measures. Diabexa offers a comprehensive product portfolio encompassing a wide range of solutions for effective diabetes management. This includes a diverse selection of medications designed to address the varying needs of diabetic patients. From oral medications to insulin therapies, we cater to diverse patient needs.

Types of Diabetic Medicine

Biguanides

(e.g., Metformin)

Reduce glucose production in the liver and improve insulin sensitivity.

Sulfonylureas

(e.g., Glipizide, Glimepiride)

Stimulate the pancreas to release more insulin.

Thiazolidinediones (TZDs)

(e.g., Pioglitazone)

Improve insulin sensitivity in peripheral tissues.

DPP-4 Inhibitors

(e.g., Sitagliptin, Linagliptin)

Increase insulin release and decrease glucagon secretion.

SGLT2 Inhibitors

(e.g., Canagliflozin, Empagliflozin)

Increase glucose excretion in the urine.

Alpha-Glucosidase Inhibitors

(e.g., Acarbose, Miglitol)

Slow down the absorption of carbohydrates.

Insulins

(Various types including rapid-acting, short-acting, intermediate-acting, long-acting)

Replace the insulin that the body is not producing or not using effectively.

GLP-1 Receptor Agonists

(e.g., Exenatide, Liraglutide, Semaglutide)

Increase insulin release, decrease glucagon secretion, slow gastric emptying, and promote satiety.

Amylin Analogs

(e.g., Pramlintide)

Slow gastric emptying and suppress glucagon secretion.

It's crucial to consult with a healthcare professional for diagnosis and treatment. This information is for general knowledge only and should not replace professional medical advice.

Empowering Partners: The Diabexa PCD Model

Diabexa operates on a PCD model, offering excellent franchise opportunities to motivated individuals and businesses seeking a rewarding partnership in the healthcare sector. Our PCD pharma franchise provides several key advantages that contribute to the success of our partners:

=\
Our Advantages
GMP Certified

WHO GMP Certified Quality

Adherence to the highest international standards, ensuring safe, effective, and consistent products.

Product Portfolio

Extensive Product Portfolio

A wide range of products to meet diverse healthcare needs, catering to various therapeutic areas.

Marketing Support

Strong Marketing and Promotional Support

Comprehensive marketing materials, strategies, and ongoing support to help you succeed.

Monopoly Rights

Monopoly Rights

Exclusive territorial rights to maximize your market reach and minimize competition.